Liraglutide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Liraglutide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Cholelithiasis | 0.3% |
| Cholecystitis | 0.2% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Liraglutide injection is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus Limitations of Use: Liraglutide injection should not be used in patients with type 1 diabetes mellitus. Liraglutide injection contains liraglutide and should not be coadministered with other liraglutide-containing products.
Source: FDA labeling via NIH DailyMed (set 1a36f43f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.